Sponsor or institution

Clinical trials and research at Fujian Cancer Hospital

• 21Clinical trials
• 1New in 30 days
• 1Country

Newest trials

All recruiting trials (21)

• Pre-Treatment Breast DCE-MRI AI Model to Predict Benefit from Neoadjuvant Chemo in Locally Advanced Triple-Negative Breast Cancer

  This study tests an AI model using pre-treatment breast MRI to see if it can identify which locally advanced triple-negative breast cancer patients will benefit most from neoadjuvant chemotherapy.

  Recruiting Fujian Cancer Hospital · Fuzhou, Fujian and 4 other locations · NCT07880600

• AI-powered pre-treatment MRI to predict chemotherapy response in HR+/HER2- breast cancer

  This study tests whether AI analysis of baseline DCE-MRI can forecast which HR+/HER2- breast cancer patients will benefit most from neoadjuvant chemotherapy.

  Recruiting at 5 sites Fujian Cancer Hospital · Fuzhou, Fujian and 4 other locations · NCT07702708

• Dalpiciclib plus hormone therapy for early HR+/HER2- breast cancer

  This trial tests whether adding dalpiciclib at two different doses and durations to standard hormone therapy helps people with early HR+/HER2- breast cancer.

  Recruiting Phase 2 Fujian Cancer Hospital · Fuzhou, Fujian and 1 other locations · NCT07581834

• Short-Course RT with CAPOX and Tislelizumab vs Long-Course RT with Tislelizumab for Locally Advanced Rectal Cancer

  This study tests whether a shorter radiotherapy course with CAPOX chemotherapy and the PD-1 blocker tislelizumab works as well as the standard longer radiotherapy approach for locally advanced rectal cancer.

  Recruiting Phase 2 Fujian Cancer Hospital · Fuzhou, Fujian and 2 other locations · NCT07469306

• Dalpiciclib with endocrine therapy, with or without low‑dose capecitabine, for HR+/HER2‑ advanced breast cancer with organ (visceral) spread

  This trial tests whether adding continuous low‑dose (metronomic) capecitabine to dalpiciclib plus endocrine therapy helps women with HR+/HER2‑ advanced breast cancer that has spread to organs.

  Recruiting Phase 3 Fujian Cancer Hospital · Fuzhou, Fujian · NCT07467330

• IMRT-only treatment for stage IB nasopharyngeal cancer without high-risk features

  This trial will test whether IMRT alone can control stage IB nasopharyngeal cancer without high-risk features in adults aged 18–70.

  Recruiting Fujian Cancer Hospital · Fuzhou, Fujian · NCT07376603

• Induction and maintenance with MRG003, Tislelizumab, and Capecitabine for locally recurrent nasopharyngeal cancer

  This study tests a treatment combo of MRG003 and a PD-1 blocker first, then continues with Capecitabine plus the PD-1 blocker to see if it helps patients with locally recurrent NPC.

  Recruiting Phase 2 Fujian Cancer Hospital · Fuzhou, Fujian · NCT07331428

• Post-surgery immunotherapy plus focal radiotherapy for NSCLC with multiple N2 lymph node metastases

  This trial will test whether adding the PD-1 drug tislelizumab (with standard platinum chemo), with or without focused radiotherapy, helps people 18–75 who had surgery for stage III NSCLC with multiple N2 lymph node metastases live longer without the cancer coming back.

  Recruiting Phase 4 Fujian Cancer Hospital · Fuzhou, Fujian · NCT07320105

• Sacituzumab tirumotecan plus QL1706 for recurrent or metastatic cervical cancer

  This study will test whether combining sacituzumab tirumotecan (a TROP2-targeted antibody‑drug conjugate) with QL1706 (a dual PD‑1/CTLA‑4 antibody) helps people with recurrent or metastatic cervical cancer who have already received platinum therapy.

  Recruiting at 2 sites Phase 2 Fujian Cancer Hospital · Fuzhou, Fujian and 13 other locations · NCT07256236

• Laparoscopic proximal gastrectomy with or without preserving the celiac branch of the vagus nerve for early upper stomach cancer

  This trial will test whether keeping the celiac branch of the vagus nerve during laparoscopic proximal gastrectomy improves stomach emptying and quality of life for people with early upper stomach or esophagogastric junction cancer.

  Recruiting Fujian Cancer Hospital · Fuzhou, Fujian · NCT07142122

• Pre-surgery iparomlimab and tuvonralimab with chemotherapy for locally advanced cervical cancer

  This phase 2 trial tests whether giving iparomlimab and tuvonralimab with chemotherapy before surgery helps people with locally advanced cervical cancer shrink their tumors and improve outcomes.

  Recruiting Phase 2 Fujian Cancer Hospital · Fuzhou, Fujian · NCT07055399

• Tislelizumab with FOLFOX versus POF for unresectable or metastatic gastric/gastroesophageal junction adenocarcinoma

  This trial tests whether adding the immunotherapy drug tislelizumab to FOLFOX works better than adding it to POF for adults with unresectable or metastatic stomach or gastroesophageal junction cancer whose tumors have CPS≥1.

  Recruiting Phase 3 Fujian Cancer Hospital · Fuzhou, Fujian · NCT06793917

• PULSAR combined with PD-1 antibody, chemotherapy, and bevacizumab for colorectal cancer that has spread to the liver

  This trial tests if adding PULSAR radiotherapy to a regimen with a PD-1 blocker, standard chemotherapy, and bevacizumab helps people with colorectal cancer liver metastases live longer without their disease getting worse.

  Recruiting Phase 2 Fujian Cancer Hospital · Fuzhou, Fujian · NCT06788171

• Short-course pelvic radiotherapy with CAPOX chemotherapy plus QL1706 immunotherapy for rectal cancer that has spread to the liver

  This Phase 2 trial will test whether short-course radiotherapy combined with CAPOX chemotherapy and the QL1706 dual PD‑1/CTLA‑4 immunotherapy helps adults with rectal cancer that has liver metastases (MSS/pMMR).

  Recruiting Phase 2 Fujian Cancer Hospital · Fuzhou, Fujian and 1 other locations · NCT06787183

• Combining Sintilimab with Chemotherapy for Esophageal Cancer Treatment

  This study is testing if combining a new drug called sintilimab with chemotherapy can help people with advanced esophageal cancer before surgery.

  Recruiting Phase 2 Fujian Cancer Hospital · Fuzhou, Fujian · NCT06463834

• Evaluating Cadonilimab for Cervical Cancer Treatment

  This study is testing a new drug called Cadonilimab to see if it can help people with persistent, recurrent, or metastatic cervical cancer feel better and live longer while also looking at its safety and costs.

  Recruiting Fujian Cancer Hospital · Fuzhou, Fujian · NCT06140589

• Geometric expansion for radiation treatment in nasopharyngeal carcinoma

  This study is testing a new way of targeting radiation treatment for patients with nasopharyngeal cancer to see if it works better and is safer for healthy tissues compared to the standard method.

  Recruiting Phase 3 Fujian Cancer Hospital · Fuzhou, Fujian · NCT06095154

• Combining adebrelimab and fuzuloparib for treating recurrent platinum-resistant ovarian cancer

  This study is testing a new combination treatment of adebrelimab and fuzuloparib to see if it helps people with recurrent platinum-resistant ovarian cancer who haven't had other systemic treatments.

  Recruiting Phase 2 Fujian Cancer Hospital · Fujian · NCT05753826

• Combination therapy for advanced gastric cancer

  This study is testing a new combination of treatments for advanced gastric cancer to see if it works better than the standard treatment for patients with larger tumors.

  Recruiting Phase 2/3 Fujian Cancer Hospital · Fuzhou, Fujian · NCT05699655

• Combining camrelizumab with chemoradiotherapy for advanced esophageal cancer

  This study is testing if adding a new immunotherapy drug called camrelizumab to standard chemotherapy and radiation can help people with advanced esophageal cancer feel better and improve their treatment results.

  Recruiting Phase 2 Fujian Cancer Hospital · Fuzhou · NCT05624099

• Combining Irinotecan and Tislelizumab for Advanced Gastric Cancer

  This study is testing a new combination of treatments for people with advanced stomach cancer to see if it is safe and effective.

  Recruiting Phase 1/2 Fujian Cancer Hospital · Fuzhou, Fujian · NCT05319639

Quick answers

How many clinical trials run by Fujian Cancer Hospital are recruiting right now?

21, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 10, Phase 3: 3, Phase 4: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →